These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4916640)

  • 1. Studies on trachoma. VII. Isolation of a mixture of type 1 and type 2. Trachoma strains from a child in Saudi Arabia.
    Bell SD; McComb DE; Nichols RL; Roca-Garcia M
    Am J Trop Med Hyg; 1970 Sep; 19(5):842-5. PubMed ID: 4916640
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on trachoma. VI. Microbiological observations in a field trial in Saudi Arabia of bivalent rachoma vaccine at three dosage levels.
    Nichols RL; Bell SD; Haddad NA; Bobb AA
    Am J Trop Med Hyg; 1969 Sep; 18(5):723-30. PubMed ID: 4897605
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative isolations of TRIC agent in the yolk sacs and the amniotic cavities of chick embryos.
    Harisijades SS; Harisijades BS
    Acta Med Iugosl; 1967; 21(2):223-30. PubMed ID: 4883476
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunofluorescent studies of the microbiologic epidemiology of trachoma in Saudi Arabia.
    Nichols RL; Bobb AA; Haddad NA; McComb DE
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1372-408. PubMed ID: 5337745
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and identification of trachoma and inclusion conjunctivitis agents in Melbourne, 1966 to 1972.
    Graham DM; Pinkard KJ; Layton JE; Greer CH; Davis JA
    Med J Aust; 1973 Jun; 1(22):1095-9. PubMed ID: 4351871
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of TRIC agent (Chlamydia) in irradiated McCoy cell culture from endemic trachoma in field studies in Iran. Comparison with other laboratory tests for detection of Chlamydia.
    Darougar S; Treharne JD; Dwyer RS; Kinnison JR; Jones BR
    Br J Ophthalmol; 1971 Sep; 55(9):591-9. PubMed ID: 4106450
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present-day characteristics of diagnosis of trachoma].
    Shatkin AA; Nurmamedov NN; Tarasova LN; Tsereteli EK
    Vestn Oftalmol; 1975; (5):72-5. PubMed ID: 798392
    [No Abstract]   [Full Text] [Related]  

  • 8. [The causal agent of trachoma (Chlamydia trachomatis) in the PLT group: simple methods of identification].
    Capponi M; Haider F
    C R Seances Soc Biol Fil; 1969; 163(5):1099-102. PubMed ID: 4259168
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the fluorescent and precipitating agglutinating antibodies of the causative agent of trachoma (Chlamydia trachomatis) in the PLT group].
    Haider F; Dodin A; Capponi M
    C R Seances Soc Biol Fil; 1970; 164(1):105-9. PubMed ID: 4248009
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotypes of trachoma agent isolated in the Gambia: with an observation on the relation between serotype and morphology.
    Sowa J; Collier LH; Sowa S
    J Hyg (Lond); 1974 Jun; 72(3):389-95. PubMed ID: 4135585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a further microimmunofluorescence serotype of Chlamydia: TRIC type G.
    Treharne JD; Darougar S; Jones BR
    Br J Vener Dis; 1973 Jun; 49(3):295-300. PubMed ID: 4578214
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia.
    Nichols RL; Bell SD; Murray ES; Haddad NA; Bobb AA
    Am J Trop Med Hyg; 1966 Jul; 15(4):639-47. PubMed ID: 5941182
    [No Abstract]   [Full Text] [Related]  

  • 13. TOXICITY OF THE AGENTS OF TRACHOMA AND INCLUSION CONJUNCTIVITIS.
    TAVERNE J; BLYTH WA; REEVE P
    J Gen Microbiol; 1964 Nov; 37():271-5. PubMed ID: 14247752
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the epidemiology, microbiology and immunology of trachoma among children at three centres in Western Australia.
    Graham DM; Nichols RL; Mann I
    Med J Aust; 1973 Aug; 2(8):353-60. PubMed ID: 4356144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isolation of Chlamydia trachomatis in trachomatous Moroccan patients].
    Takourt B; Milad A; Radouani F; Boura H; Guinet R; Benslimane A
    J Fr Ophtalmol; 1996; 19(8-9):527-32. PubMed ID: 8944135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan.
    Mahmoud E; Elshibly S; Mardh PA
    Am J Trop Med Hyg; 1994 Oct; 51(4):489-94. PubMed ID: 7943577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pathobiology of TRIC agents].
    Jawetz E
    Rev Int Trach; 1973; 50(3):27-38. PubMed ID: 4780351
    [No Abstract]   [Full Text] [Related]  

  • 18. Trachoma vaccine field trials in The Gambia.
    Sowa S; Sowa J; Collier LH; Blyth WA
    J Hyg (Lond); 1969 Dec; 67(4):699-717. PubMed ID: 5261212
    [No Abstract]   [Full Text] [Related]  

  • 19. Further characterization of TRIC agent strains of genital origin.
    Alexander ER; Wang SP; Grayston JT
    Rev Int Trach; 1968; 45(4):297-310. PubMed ID: 4992514
    [No Abstract]   [Full Text] [Related]  

  • 20. The noninfectivity of stage IV of trachoma.
    Maythar B
    Am J Ophthalmol; 1970 Mar; 69(3):486-7. PubMed ID: 4907467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.